Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Mast cell degranulation – a mechanism for the anti‐arrhythmic effect of endothelin‐1?

Mast cell degranulation – a mechanism for the anti‐arrhythmic effect of endothelin‐1? Background and purpose: The aim of this study was to investigate whether the previously reported anti‐arrhythmic effect of endothelin‐1 (ET‐1) is mediated by degranulation of cardiac mast cells prior to myocardial ischaemia. Experimental approach: Male Sprague‐Dawley rats received either ET‐1 (1.6 nmol·kg−1) in the presence or absence of disodium cromoglycate (DSCG; 20 mg·kg−1·h−1) prior to coronary artery occlusion (CAO). In separate experiments rats were given compound 48/80 (50 µg·kg−1) to compare the effects of ET‐1 with those of a known mast cell degranulator. Ischaemia‐induced ventricular arrhythmias were detected through continuous monitoring of a lead I electrocardiogram. After 30 min of CAO, the hearts were removed and mast cell degranulation determined by histological analysis. A parallel series of sham groups were performed to determine the direct effects of ET‐1 and compound 48/80 on mast cell degranulation in the absence of ischaemia. Key results: ET‐1 and compound 48/80 both exerted profound anti‐arrhythmic effects, significantly reducing the total number of ventricular ectopic beats (P < 0.001) and the incidence of ventricular fibrillation (P < 0.05). These anti‐arrhythmic effects were abolished by concomitant DSCG infusion prior to CAO. In sham animals ET‐1 and compound 48/80 both induced mast cell degranulation (P < 0.001), an effect which was abolished by DSCG, confirming their ability to induce degranulation of mast cells. Conclusions and implications: These results demonstrate for the first time that when given prior to ischaemia ET‐1 mediates its anti‐arrhythmic effects, at least in part, via cardiac mast cell degranulation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png British Journal of Pharmacology Wiley

Mast cell degranulation – a mechanism for the anti‐arrhythmic effect of endothelin‐1?

Loading next page...
 
/lp/wiley/mast-cell-degranulation-a-mechanism-for-the-anti-arrhythmic-effect-of-GOZdKQptAl

References (45)

Publisher
Wiley
Copyright
© 2009 The Authors. Journal compilation © 2009 The British Pharmacological Society
ISSN
0007-1188
eISSN
1476-5381
DOI
10.1111/j.1476-5381.2009.00222.x
pmid
19422371
Publisher site
See Article on Publisher Site

Abstract

Background and purpose: The aim of this study was to investigate whether the previously reported anti‐arrhythmic effect of endothelin‐1 (ET‐1) is mediated by degranulation of cardiac mast cells prior to myocardial ischaemia. Experimental approach: Male Sprague‐Dawley rats received either ET‐1 (1.6 nmol·kg−1) in the presence or absence of disodium cromoglycate (DSCG; 20 mg·kg−1·h−1) prior to coronary artery occlusion (CAO). In separate experiments rats were given compound 48/80 (50 µg·kg−1) to compare the effects of ET‐1 with those of a known mast cell degranulator. Ischaemia‐induced ventricular arrhythmias were detected through continuous monitoring of a lead I electrocardiogram. After 30 min of CAO, the hearts were removed and mast cell degranulation determined by histological analysis. A parallel series of sham groups were performed to determine the direct effects of ET‐1 and compound 48/80 on mast cell degranulation in the absence of ischaemia. Key results: ET‐1 and compound 48/80 both exerted profound anti‐arrhythmic effects, significantly reducing the total number of ventricular ectopic beats (P < 0.001) and the incidence of ventricular fibrillation (P < 0.05). These anti‐arrhythmic effects were abolished by concomitant DSCG infusion prior to CAO. In sham animals ET‐1 and compound 48/80 both induced mast cell degranulation (P < 0.001), an effect which was abolished by DSCG, confirming their ability to induce degranulation of mast cells. Conclusions and implications: These results demonstrate for the first time that when given prior to ischaemia ET‐1 mediates its anti‐arrhythmic effects, at least in part, via cardiac mast cell degranulation.

Journal

British Journal of PharmacologyWiley

Published: Jul 1, 2009

There are no references for this article.